Selective mRNA translation determines adaptative mutability of melanoma cells to anti-BRAF/MEK combination therapy
Lucilla Fabbri(Institut Curie), Stéphan Vagner(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
53BP1 interacts with the RNA primer from Okazaki fragments to support their processing during unperturbed DNA replication
|Cell Reports|2023|18
MET functions in tumour progression and therapy resistance are repressed by intronic polyadenylation
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0